Log in to save to my catalogue

Ambra1 modulates the sensitivity of breast cancer cells to epirubicin by regulating autophagy via AT...

Ambra1 modulates the sensitivity of breast cancer cells to epirubicin by regulating autophagy via AT...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6172055

Ambra1 modulates the sensitivity of breast cancer cells to epirubicin by regulating autophagy via ATG12

About this item

Full title

Ambra1 modulates the sensitivity of breast cancer cells to epirubicin by regulating autophagy via ATG12

Publisher

England: John Wiley & Sons, Inc

Journal title

Cancer science, 2018-10, Vol.109 (10), p.3129-3138

Language

English

Formats

Publication information

Publisher

England: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

The sensitivity of breast cancer cells to epirubicin (EPI) is closely related to the efficacy of the drug and the prognosis of patients. A growing body of research has suggested that autophagy is involved in the treatment of a variety of cancers, including breast cancer, and modifies the sensitivity of anticancer drugs. However, the mechanism by wh...

Alternative Titles

Full title

Ambra1 modulates the sensitivity of breast cancer cells to epirubicin by regulating autophagy via ATG12

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6172055

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6172055

Other Identifiers

ISSN

1347-9032

E-ISSN

1349-7006

DOI

10.1111/cas.13743

How to access this item